Skip to main content
Advanced Technical In the Industry Vocabulary Test

tumor lysis syndrome

Metabolic emergency caused by rapid tumor cell destruction releasing intracellular contents into circulation.

Full Definition

Tumor lysis syndrome (TLS) is a potentially life-threatening metabolic complication that occurs when large numbers of tumor cells are destroyed rapidly, typically following cytotoxic therapy. The massive cell death releases intracellular contents including potassium, phosphorus, and nucleic acids into the bloodstream, leading to hyperkalemia, hyperphosphatemia, hyperuricemia, and secondary hypocalcemia. While more common in hematologic malignancies, TLS can occur in rapidly growing solid tumors including some gynecologic cancers, particularly when tumor burden is high.

Usage

Usage note: Often abbreviated as TLS in clinical documentation.

In Context

  • "The patient developed tumor lysis syndrome following her first cycle of chemotherapy." — emergency department note
  • "Prophylactic measures were implemented to prevent tumor lysis syndrome given the large tumor burden." — treatment plan

Also known as

TLS

Don't confuse with

tumor progression chemotherapy toxicity

Editors from these organizations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON